Matt Wolsfeld
Analyst · Axiom Capital. Your line is open
Thanks, Patrick. Sales of NTIC's ZERUST products increased across all market segments during fiscal 2014. Sales of individual ZERUST corrosion inhibiting products increased over 16% as we saw demand increase in both existing customers and new customers. Sales of ZERUST Oil & Gas solutions increased over 71% in fiscal 2014 as we completed many implementations at multiple new customer sites in North America. Additionally, we experienced an increase in oil and gas sales in the Brazilian market. It's also important to note that our gross margins improved over 2% during fiscal 2014, compared to fiscal 2013. Sales of ZERUST corrosion inhibiting products to our joint ventures increased over 16% in fiscal 2014. This increase was mostly a function of the overall increase in joint venture sales of 5% during the period, as Patrick noted earlier. Additionally, income provided by our joint venture operations increased almost 12% to almost $14.1 million during fiscal 2014, compared to fiscal 2013. Lastly, sales of Natur-Tec products increased over 45% to almost $3 million during fiscal 2014, compared to fiscal 2013. Our total operating expenses increased almost 12% to $16.4 million for fiscal 2014, primarily due to an increase in selling expenses, general and administrative expenses, and research and development expenses, and overall, reflected our efforts to support our new business efforts. Overall, net income attributable to NTIC increased 22% to over $4.1 million or $0.90 per diluted common share for fiscal 2014, compared to $0.75 during fiscal 2013. As of August 31, 2014, our working capital increased to $17.8 million, including $2.5 million in cash and cash equivalents and $5.5 million in available for sale securities, compared to $13.3 million in cash and cash equivalents at August 31, 2013. Regarding NTIC's annual guidance; for fiscal year ending August 31, 2015, NTIC expected net sales to range between $32 million and $34 million, inclusive of sales made by NTIC's majority-owned subsidiary in Brazil, and expect net income of between $5.4 million to $5.7 million or between $1.20 and $1.26 per diluted share. With that financial update, Patrick and I'll now answer any questions you may have.